Other Current Liabilities - Nanobiotix SA (PAR:NANO) - Alpha Spread

Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.584 EUR -1.33%
Market Cap: 217.3m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Nanobiotix SA
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nanobiotix SA
Other Current Liabilities Peer Comparison

Comparables:
VLA
IPH
GNFT
ALERS
OSE

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Nanobiotix SA
PAR:NANO
Other Current Liabilities
€37.9m
CAGR 3-Years
67%
CAGR 5-Years
54%
CAGR 10-Years
44%
Valneva SE
PAR:VLA
Other Current Liabilities
€29.9m
CAGR 3-Years
-56%
CAGR 5-Years
19%
CAGR 10-Years
21%
Innate Pharma SA
PAR:IPH
Other Current Liabilities
€3.2m
CAGR 3-Years
-42%
CAGR 5-Years
-41%
CAGR 10-Years
12%
Genfit SA
NASDAQ:GNFT
Other Current Liabilities
€15.9m
CAGR 3-Years
103%
CAGR 5-Years
100%
CAGR 10-Years
17%
Eurobio Scientific SA
PAR:ALERS
Other Current Liabilities
€18.7m
CAGR 3-Years
-2%
CAGR 5-Years
24%
CAGR 10-Years
23%
OSE Immunotherapeutics SA
PAR:OSE
Other Current Liabilities
€372k
CAGR 3-Years
-30%
CAGR 5-Years
-11%
CAGR 10-Years
N/A

See Also

What is Nanobiotix SA's Other Current Liabilities?
Other Current Liabilities
37.9m EUR

Based on the financial report for Dec 31, 2023, Nanobiotix SA's Other Current Liabilities amounts to 37.9m EUR.

What is Nanobiotix SA's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
44%

Over the last year, the Other Current Liabilities growth was 40%. The average annual Other Current Liabilities growth rates for Nanobiotix SA have been 67% over the past three years , 54% over the past five years , and 44% over the past ten years .

Back to Top